NZ514883A - Anti-bacterial vaccine compositions - Google Patents

Anti-bacterial vaccine compositions

Info

Publication number
NZ514883A
NZ514883A NZ514883A NZ51488300A NZ514883A NZ 514883 A NZ514883 A NZ 514883A NZ 514883 A NZ514883 A NZ 514883A NZ 51488300 A NZ51488300 A NZ 51488300A NZ 514883 A NZ514883 A NZ 514883A
Authority
NZ
New Zealand
Prior art keywords
atpg
gene
decreased
biological activity
activity
Prior art date
Application number
NZ514883A
Other languages
English (en)
Inventor
David E Lowery
Troy E Fuller
Michael J Kennedy
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NZ514883A publication Critical patent/NZ514883A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NZ514883A 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions NZ514883A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12868999P 1999-04-09 1999-04-09
US15345399P 1999-09-10 1999-09-10
PCT/US2000/009218 WO2000061724A2 (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions

Publications (1)

Publication Number Publication Date
NZ514883A true NZ514883A (en) 2004-03-26

Family

ID=26826843

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ530012A NZ530012A (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions
NZ514883A NZ514883A (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ530012A NZ530012A (en) 1999-04-09 2000-04-06 Anti-bacterial vaccine compositions

Country Status (14)

Country Link
US (5) US20070237793A1 (enExample)
EP (5) EP2281833B1 (enExample)
JP (4) JP4892134B2 (enExample)
KR (4) KR20060116041A (enExample)
CN (1) CN1351653A (enExample)
AR (1) AR029622A1 (enExample)
AU (2) AU780887B2 (enExample)
BR (1) BR0009663A (enExample)
CA (1) CA2366520C (enExample)
ES (2) ES2439645T3 (enExample)
HK (1) HK1045856A1 (enExample)
MX (1) MXPA01010207A (enExample)
NZ (2) NZ530012A (enExample)
WO (1) WO2000061724A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4124732B2 (ja) 2001-09-26 2008-07-23 協和醗酵工業株式会社 α１，４−ガラクトース転移酵素およびガラクトース含有複合糖質の製造法
DE60230717D1 (de) * 2002-04-05 2009-02-26 Merial Sas Attenuirte Gram-negative Bakterien
US7449178B2 (en) 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
GB0228691D0 (en) * 2002-12-09 2003-01-15 Imp College Innovations Ltd Bacterial virulence genes
ATE486936T1 (de) * 2003-03-05 2010-11-15 Chemo Sero Therapeut Res Inst Verfahren zur herstellung eines heterologen proteins in e. coli
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
EP2073829B1 (en) * 2006-10-05 2012-06-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
JP2011522796A (ja) 2008-05-06 2011-08-04 ニューヨーク ブラッド センター， インコーポレイテッド 抗ウイルス細胞透過性ペプチド
DE102011016772B8 (de) * 2011-04-12 2024-08-14 Mercedes-Benz Group AG Verfahren und Vorrichtung zur Überwachung zumindest eines Fahrzeuginsassen und Verfahren zum Betrieb zumindest einer Assistenzvorrichtung
US9757445B2 (en) 2013-11-01 2017-09-12 Merial Inc. Attenuated Pasteurella multocida vaccines and methods of making and use thereof
ES2945137T3 (es) 2017-02-10 2023-06-28 Epitopix Llc Proteínas y composiciones inmunitarias que contienen proteínas de Pasteurella y métodos de uso
TW202219269A (zh) 2020-09-30 2022-05-16 美國農業部 新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗
TW202214294A (zh) 2020-09-30 2022-04-16 美商碩騰服務公司 具有ｈｙａＣ及ｎａｎＰ缺失之新穎多殺性巴斯德氏菌株及疫苗
CN113567415A (zh) * 2021-07-05 2021-10-29 广西大学 表面增强拉曼散射结合免疫层析技术检测布鲁氏杆菌方法
CN115925536B (zh) * 2022-08-01 2025-02-28 北京农学院 靶向抑制DksA的小分子抑制剂和应用
CN116593695B (zh) * 2022-12-29 2025-08-05 重庆澳龙生物制品有限公司 一种牛多杀性巴氏杆菌荚膜a型elisa抗体检测试剂盒及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
DE3426532A1 (de) 1984-07-18 1986-01-30 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Verwendung einer dna-sequenz zur expression sowie dna-struktur und expressionsvektor mit der dna-sequenz
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
DK166762B1 (da) 1986-01-14 1993-07-12 Nederlanden Staat Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
DK46693D0 (enExample) * 1993-04-23 1993-04-23 Novo Nordisk As
PL170938B1 (pl) * 1991-03-05 1997-02-28 Wellcome Found Sposób wytwarzania szczepionki przeciwko infekcjom Salmonella PL PL
US5840312A (en) * 1991-05-02 1998-11-24 Institut Pasteur Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
US5585277A (en) 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
WO1995020652A1 (de) 1994-01-28 1995-08-03 Medigene Gmbh Verfahren zur bestimmung der aktivität eines regulatorischen faktors sowie verwendung dieses verfahrens
DE69535674T2 (de) 1994-08-30 2009-01-02 Ajinomoto Co., Inc. Verfahren zur herstellung von l-valin und l-leucin
KR100445103B1 (ko) * 1994-12-09 2004-12-04 임페리얼 컬리지 이노베이션스 리미티드 유전자의동정
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
US6355450B1 (en) 1995-04-21 2002-03-12 Human Genome Sciences, Inc. Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
US5994066A (en) 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US5925354A (en) * 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
US5840556A (en) * 1996-05-08 1998-11-24 The United States Of America As Represented By The Department Of Agriculture Molecular genetic construction of vaccine strains of pasteurellaceae
JPH1075774A (ja) * 1996-05-31 1998-03-24 Akzo Nobel Nv パスツレラ科の弱毒化ｒｔｘ産生細菌
US6020474A (en) 1997-01-15 2000-02-01 Incyte Pharmaceuticals, Inc. ATP synthase subunits
US6673538B1 (en) 1997-07-25 2004-01-06 The Trustees Of Boston University Methods and compositions for designing vaccines
US6790950B2 (en) 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
AU7131600A (en) 1999-06-21 2001-01-09 North Carolina State University Acid-inducible promoters for gene expression
US6376211B1 (en) 1999-07-12 2002-04-23 Xoma Technology Ltd. Agents and methods for inhibiting F1/F0 ATPase

Also Published As

Publication number Publication date
JP5377433B2 (ja) 2013-12-25
JP2016019528A (ja) 2016-02-04
KR20060116041A (ko) 2006-11-13
US9289486B2 (en) 2016-03-22
US8974798B2 (en) 2015-03-10
CA2366520C (en) 2013-10-01
CN1351653A (zh) 2002-05-29
EP2281834A2 (en) 2011-02-09
EP2281835A2 (en) 2011-02-09
CA2366520A1 (en) 2000-10-19
US20090202594A1 (en) 2009-08-13
HK1045856A1 (zh) 2002-12-13
EP2281834A3 (en) 2011-11-23
AU2005203189B2 (en) 2007-12-20
WO2000061724A2 (en) 2000-10-19
EP1860117A2 (en) 2007-11-28
ES2439645T3 (es) 2014-01-24
JP4892134B2 (ja) 2012-03-07
KR20010112937A (ko) 2001-12-22
AR029622A1 (es) 2003-07-10
EP1171577A2 (en) 2002-01-16
EP2281834B1 (en) 2015-03-04
BR0009663A (pt) 2002-04-09
AU4077600A (en) 2000-11-14
EP2281833B1 (en) 2014-07-02
WO2000061724A3 (en) 2001-02-01
US20100322975A1 (en) 2010-12-23
ES2535961T3 (es) 2015-05-19
JP2002541790A (ja) 2002-12-10
NZ530012A (en) 2005-10-28
JP5973634B2 (ja) 2016-08-23
US20120148625A1 (en) 2012-06-14
US20070237793A1 (en) 2007-10-11
JP2013121347A (ja) 2013-06-20
EP2281833A2 (en) 2011-02-09
EP2281835B1 (en) 2013-11-06
EP1860117A3 (en) 2008-09-03
JP2010284165A (ja) 2010-12-24
KR20060134225A (ko) 2006-12-27
KR20070011622A (ko) 2007-01-24
AU2005203189A1 (en) 2005-08-18
AU780887B2 (en) 2005-04-21
US7763262B2 (en) 2010-07-27
EP2281835A3 (en) 2011-11-23
MXPA01010207A (es) 2003-07-21
EP2281833A3 (en) 2011-11-30
US20150182615A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
NZ514883A (en) Anti-bacterial vaccine compositions
Young et al. A bifunctional urease enhances survival of pathogenic Yersinia enterocolitica and Morganella morganii at low pH
Marshall et al. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms
KR101482015B1 (ko) 세린 프로테아제, 세린 효소들을 인코딩하는 핵산 및 이를편입시킨 벡터 및 숙주 세포
Archer et al. Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus
SG165157A1 (en) Identification of genes
EP1167542A3 (en) Probe for diagnosing infectious disease arising from Enterococcus faecalis
WO1999034003A3 (en) Proteases from gram positive organisms
WO1999033960A3 (en) Proteases from gram positive organisms
AR035745A1 (es) Bacteria gram-negativa, una composicion inmunogena, una composicion para vacunas, un metodo para producir un mutante, un polinucleotido de pasteurellaceae purificado y aislado, un vector, una celula transformada establemente o transfectada, metodo para producir un polipeptido recombinante, anticuerp
MacKinnon et al. Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain
AU2003223447A1 (en) Attenuated gram negative bacteria
Stepanović et al. Brain abscess due to Actinobacillus actinomycetemcomitans: Case report
EP1108786A4 (en) NEW COLLECTIN
EP1047710B1 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
Robinson et al. X chromosome evolution in the suni and eland antelope: detection of homologous regions by fluorescence in situ hybridization and G-banding
PT1164190E (pt) Gene da artrite reumatóide e método para o diagnóstico da artrite reumatóide
PT1350796E (pt) Bactérias gram-negativas atenuadas
ATE318933T1 (de) Nukleinsäurefragmente zur identifizierung von dechlorierenden bakterien
GB9724627D0 (en) Gram positive microorganism formate pathway
ATE399209T1 (de) Verfahren zur herstellung von coenzym q 10
GB9321302D0 (en) Enzyme
GB9321325D0 (en) Microorganism and its use
TW200700555A (en) Saponin-decomposing enzyme, gene thereof and large-scale production system for producing soyasapogenol b
AU710730B2 (en) Method to predict active growth of bacteria adhered to a surface

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)